Allergan plc (AGN)

193.02
0.03 0.02
NYSE
Prev Close 192.99
Open 193.01
Day Low/High 191.64 / 193.38
52 Wk Low/High 114.27 / 202.22
Volume 12.44M
Exchange NYSE
Div & Yield N.A. (N.A)

Allergan Posts Modest Beat

As expected, Allergan reported solid results that modestly beat consensus estimates.    I am trying to add in premarket trading in order to bring this position to large in size.   Sales rose by about $100 million more than expected and the bottom li...

The Worm Has Obviously Turned: Market Recon

The Worm Has Obviously Turned: Market Recon

Firms that adapted to hard times are now doing exponentially better.

Here's What Jim Cramer Expects From Allergan's Results

Here's What Jim Cramer Expects From Allergan's Results

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is worried about how much Facebook has run up in anticipation of the earnings.

Retail and Biotech Are Horror Shows

Retail and biotech just continue to be horrific performers -- across the board. And, given their vulnerability to year-end tax-loss selling, I don't see a respite over the next two months. I remain long only Dillard's (retail) and Allergan (biotech)...

Discovering a True Value

Discovering a True Value

Revenues, cash flow and EPS are higher than ever for Discovery Communications.

Another Abnormal Day

"Pachalafaka, pachalafaka they whisper it all over Turkey pachalafaka, pachalafaka it sounds so romantic and perky oh I know that phrase will make me thrill always for it reminds me of you, my sweet just the mention of that tender word of love gives...

And for Those Keeping Score ...

Here are my trades to this point today. I added to my Allergan long.   I initiated a General Motors short and added to my Amazon short.

Allergan Wins Chinese Nod for Ozurdex

For a change, some good drug approval news (out of China) for Allergan this morning.    I am medium in size in this name.

Adjusting Allergan and Hartford

I have lowered today's Allergan buy average to $177.35 and I have added to my Hartford Financial Group long.  

Here's Where I Bought Allergan

My average price on today's Allergan buy is $177.87.

Buying More Allergan on Biotech Weakness

This morning I added to Allergan on weakness in biotech -- a true contrarian and counterintuitive bet considering the struggles of Celgene et al. However, I am still only medium in size in my AGN position.

Average Buy on Allergan

My average buy on Allergan was $178.85 today. Still medium sized.

Allergan Slips, and I Buy

The dip of death for Allergan , as the shares traded down to $179 this morning, may have been a successful test.   I added into the decline.

It May Be Time to Buy Allergan ... I Am!

This afternoon I have moved from small sized to medium sized in Allergan at $183.50. * The last tranche of sales I made of AGN was almost $30 higher than the current price. Since then the company has been legally challenged in an important product o...

Don't Panic About Biotech

Don't Panic About Biotech

Diversification is absolutely critical when investing in this sector.

My (Brief) Takeaways and Observations

With thirty minutes to go: * Watching CNBC and the rest of the business media, one would conclude that "everyone is in the pool." It is, as one talking head just declared..."a buy/buy scenario." (Enough said/written). * The bond market's decline was...

Cramer: How to Find the Open Receiver in a Pullback

Cramer: How to Find the Open Receiver in a Pullback

You've got to run the stock checkdown.

Allergan's Hard Fall Is Not Enough of a Reason to Buy

Allergan's Hard Fall Is Not Enough of a Reason to Buy

AGN could make a capitulation low but it is a long way from making a bottom formation.

Allergan Still Slipping; I'm Not Buying (Yet)

Allergan is now about $30 below my recent sale only a few weeks ago.   I have not yet added back to this name.

Allergan Cut to Neutral at Mizuho

Cramer: What's Tax Reform Got to Do With It?

Cramer: What's Tax Reform Got to Do With It?

Treasury secretary says it's baked into the market, but is anyone really counting on it?

Recommended Allergan Reading

Barron's discusses the $1.5 billion hole in Allergan .   My thoughts remain the same -- among other things, upside to estimates no longer exists and my AGN position remains small. Nevertheless, AGN's valuation is quite reasonable and I would be a bu...

Cramer: Stocks May Be Cheaper Than We Think

Cramer: Stocks May Be Cheaper Than We Think

There's a case to be made for underpricing, even in this market.

Should You Listen to a Talking Head?

"Everyone is putting money in the market, so you might as well follow."  -- CNBC talking head  In the aggregate, the markets were uneventful -- with another remarkably narrow range in the S&P Index.  But there were some major movers.  On the upside,...

Cramer: Getting Out the Bad News Gives a Post-Earnings Boost

Cramer: Getting Out the Bad News Gives a Post-Earnings Boost

When management gets ahead of bad news, it allows a stock to prosper when the company reports earnings.

Allergan Is the 'Cheapest Big-Cap Drug Stock in the Universe': Cramer

Allergan Is the 'Cheapest Big-Cap Drug Stock in the Universe': Cramer

Stockpicker plans to buy more AGN if it drops another $5 or so.

Adverse Allergan Ruling Draws Mixed Reactions

"We are disappointed by the Federal District Court's decision on the Restasis patents. We are carefully reviewing the decision and are considering all options. Allergan remains committed to vigorously defending the intellectual property of our produ...

Allergan Hit on Restasis Decision

Allergan has continued to decline today on a just received and adverse court decision on Restasis patents.   Here are my recent thoughts on the name.     

Trump Hits Pharma

"Drug companies are getting away with murder." - PresidentTrump   And these words, corralling fears of drug price controls, are taking down Allergan , Teva (which I would sell), big pharma shares and other drug company share prices now.   My sole in...

My Takeaways and Observations

"While options can give market participants the protection they are intended to provide, they can also increase the degree of a counter move, once it gets going, as those who wrote the protection scramble to unwind their own exposure." -- Kass Diary...